Form 4: HealthLynked CEO Michael Dent Reports Acquisition of Convertible Notes and Expiration of Warrants
SEC Form 4 Filing
Michael Dent, CEO of HealthLynked Corp, reports the acquisition of convertible notes through a trust and the expiration of warrants.
Summary
- Michael Dent, the CEO of HealthLynked Corp, filed a Form 4 detailing changes in beneficial ownership.
- The report includes the acquisition of several convertible notes by the Mary S. Dent Gifting Trust, for which Michael Dent serves as trustee.
- These notes were purchased on various dates in 2024 and 2025, with conversion prices ranging from $0.023 to $0.0573.
- The notes are convertible into common stock at the specified prices, potentially resulting in the issuance of millions of shares.
- The report also indicates that warrants received in 2015 and 2018, exercisable at $0.05 and $0.065 respectively, expired unexercised on January 1, 2025.
- The trust holds the convertible notes and warrants indirectly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports transactions. The expiration of warrants could be seen as slightly negative, while the acquisition of convertible notes is a standard financial activity.
Negatives
- Warrants to purchase a significant number of shares expired unexercised, indicating a potential missed opportunity for profit.
Risks
- The conversion of the acquired notes could lead to dilution of existing shareholders' equity.
- The value of the convertible notes is dependent on the future performance of HealthLynked's stock.
Industry Context
Form 4 filings are standard practice for company insiders to report changes in their ownership of company securities, providing transparency to investors.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the US, ensuring transparency of insider transactions.
- The acquisition of convertible notes by a CEO's trust is not uncommon, but the terms and potential dilution impact are key factors for investors to consider.
- Similar filings can be observed across various companies, such as filings by executives at Teladoc Health or GoodRx, when they exercise stock options or trade company shares.
Related Party Transactions
- The acquisition of convertible notes by the Mary S. Dent Gifting Trust, for which Michael Dent is the trustee, constitutes a related party transaction.
Stakeholder Impact
- The potential conversion of the notes could dilute existing shareholders.
- The expiration of warrants may impact warrant holders.
Key Dates
| Date | Description |
|---|---|
| January 31, 2006 | Date of the Mary S. Dent Gifting Trust |
| February 12, 2018 | Date warrants were received as an inducement to extend maturity dates on then-outstanding loans. |
| March 27, 2024 | Date of earliest transaction reported (purchase of convertible notes). |
| April 18, 2024 | Date of convertible note purchase. |
| December 04, 2024 | Date of convertible note purchase. |
| December 17, 2024 | Date of convertible note purchase. |
| December 31, 2024 | Date of convertible note and warrant acquisition. |
| January 01, 2025 | Expiration date of warrants received in 2015 and 2018. |
| March 04, 2025 | Date of convertible note purchase. |
| March 12, 2025 | Date of convertible note purchase. |
| March 20, 2025 | Date of convertible note and warrant acquisition. |
| March 24, 2025 | Date of signature on the Form 4. |
| June 27, 2025 | Expiration date of convertible notes purchased on 03/27/2024. |
| July 01, 2025 | Expiration date of convertible notes purchased on 12/31/2024. |
| September 04, 2025 | Expiration date of convertible notes purchased on 03/04/2025. |
| September 12, 2025 | Expiration date of convertible notes purchased on 03/12/2025. |
| September 20, 2025 | Expiration date of convertible notes purchased on 03/20/2025. |
| December 31, 2034 | Expiration date of warrants acquired on 12/31/2024. |
| March 20, 2035 | Expiration date of warrants acquired on 03/20/2025. |
Keywords
HealthLynked, Michael Dent, Convertible Notes, Warrants, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.